A Phase I Study of Pazopanib in Combination With Trabectedin, Ipilimumab and Nivolumab (TraPIN) in Pediatric and Young Adult Patients With Recurrent Soft Tissue Sarcomas
for Soft Tissue Sarcomas
Drug: Ipilimumab
1 location in Houston
Sponsor: M.D. Anderson Cancer Center
Sex: All·Age: 1 - 30
Code: NCT07444619·Phase 1·Not Yet Recruiting